FINWIRES · TerminalLIVE
FINWIRES

BMOによるカナダの州債利回りに関する見解

By

-- モントリオール銀行(BMO)によると、カナダの州債長期利回りは過去1ヶ月間プラスとなり、カナダ国債(GoC)利回りは概ね横ばいだった一方、スプレッドは縮小した。 同行は5月の「州債信用動向レポート」の中で、予算編成シーズンが終盤を迎える中、4月を通して州債長期スプレッドは約8ベーシスポイント縮小したと述べている。 カナダ銀行は4月も政策金利を据え置き、市場は引き続き年内の利上げを織り込んでいる。これは、原油価格の高騰がカナダのコアインフレ率を押し上げ、その範囲を拡大させるとの懸念によるものだ。 BMOによると、1年前と比較すると、州債長期利回りは引き続きカナダ国債を上回っているものの、トータルリターンは「控えめな」1.5%にとどまっている。 同行は、4月を通して全ての州でスプレッドが縮小したが、突出したパフォーマンスを示した州はなかったと指摘している。予算編成シーズンが終了した現在、ブリティッシュコロンビア州は信用格付けの悪化により、オンタリオ州に後れを取っている。 アルバータ州とサスカチュワン州は、イラン紛争による原油価格の高騰直前に予算案を提出したが、市場は両州の価格差を縮小させ、オンタリオ州と同水準に戻した、とBMOは付け加えた。ケベック州は、この秋の不確実な政治情勢を前に、引き続きオンタリオ州に後れを取っている。

Related Articles

Australia

American Electric Power CEO Says Speed to Market Key Issue in Load Connection

American Electric Power (AEP) CEO Bill Fehrman said Tuesday that speed to market is the main issue in efficiently connecting energy load to generation.In a Q1 earnings call, Fehrman said that, in particular, the performance and stakeholder approval process of PJM, the US mid-Atlantic grid operator, represents a major challenge."The current state of PJM's performance and stakeholder approval process does not give me great confidence that these issues will be resolved any time soon," Fehrman said on the call."In fact, if something is not done now, I expect we could still be having these same conversations in 10 years," he added.Expanding and strengthening the grid will ensure new generation resources can connect quickly, reliably, and affordably to serve the growing load, the CEO said.Price: $137.27, Change: $+2.61, Percent Change: +1.94%

$AEP
Australia

MGE Energy Q1 Earnings, Revenue Rise

MGE Energy (MGEE) reported Q1 earnings Tuesday of $1.32 per diluted share, up from $1.14 a year earlier.One analyst polled by FactSet expected $1.13.Revenue for the three months ended March 31 was $242.7 million, up from $219 million a year earlier.Price: $80.48, Change: $+0.36, Percent Change: +0.46%

$MGEE
Research

Research Alert: CFRA Lowers Rating On Shares Of Pfizer Inc. To Hold From Buy

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our target to $28 from $31, 9.4x our 2027 EPS estimate, below PFE's historical forward P/E average. We keep our 2026 EPS view at $2.99 and our 2027 EPS at $2.97. PFE delivered solid top- and bottom-line Q1 results today that exceeded expectations while demonstrating continued progress in its post-Covid transition strategy. While we continue to think that shares are trading at a discount, as the company's main focus in the next year is on AI integration, and a new transformative M&A is not a key priority, we see limited catalysts to drive meaningful upside potential. We think PFE is aiming to maximize value from launched and acquired products with particular focus on key areas: oncology, obesity/metabolic disease, and vaccines. PFE remains committed to maintaining its dividend, continuing productivity initiatives ($7.2B cost savings target), and pursuing targeted business development (with $7B capacity) but we do not expect PFE executing share buybacks to support the share price in the near term.

$PFE